Not applicableUnknownNCT02069067What this trial is testingObservational Study of Incidence of Breakthrough Cancer Pain and How it is TreatedWho this might be right forAdvanced Cancer National Cancer Institute, Naples 500
Testing effectiveness (Phase 2)Study completedNCT01068392What this trial is testingOxaliplatin and Prednisolone (Ox-P) for Patients With Relapsed or Refractory Marginal Zone B-cell Lymphoma(MZL)Who this might be right forB-cell Lymphomas Dong-A University Hospital 42
Early research (Phase 1)Ended earlyNCT05289492What this trial is testingStudy of Novel Regimens in Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma iTeos Therapeutics 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT04124497What this trial is testingA Trial for Relapsed and Relapsed/Refractory Multiple Myeloma PatientsWho this might be right forMultiple MyelomaDeletion 17P Syndrome Fondazione EMN Italy Onlus 45
Testing effectiveness (Phase 2)Study completedNCT00051597What this trial is testingA Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic MalignanciesWho this might be right forHodgkin DiseaseLymphoma, Large-CellSarcoma, Kaposi+2 more Seagen Inc. 70
Not applicableUnknownNCT06205823What this trial is testingCompare Clinical Outcomes Between Advanced Immunotherapy and Classical Immunochemotherapy in RRMMWho this might be right forMyeloma Multiple Seoul St. Mary's Hospital 1,600
Early research (Phase 1)Study completedNCT03915379What this trial is testingJNJ-67571244 in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)Who this might be right forLeukemia, Myeloid, AcuteMyelodysplastic Syndromes Janssen Research & Development, LLC 68
Early research (Phase 1)Study completedNCT02222688What this trial is testingUC-961 (Cirmtuzumab) in Relapsed or Refractory Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia Thomas Kipps 26
Early research (Phase 1)Ended earlyNCT03579888What this trial is testingCD19-Specific T Cells Post AlloSCTWho this might be right forB Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A RearrangedRecurrent B Acute Lymphoblastic LeukemiaRecurrent Chronic Lymphocytic Leukemia+14 more M.D. Anderson Cancer Center 4
Early research (Phase 1)Study completedNCT00554827What this trial is testingStudy of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell LymphomaWho this might be right forCutaneous T-cell Lymphoma Acrotech Biopharma Inc. 55
Early research (Phase 1)Study completedNCT00730613What this trial is testingCellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant GliomaWho this might be right forBrain and Central Nervous System Tumors City of Hope Medical Center 3
Early research (Phase 1)Study completedNCT01689220What this trial is testingSP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL) in KoreaWho this might be right forPeripheral T-cell Lymphoma Solasia Pharma K.K. 6
Testing effectiveness (Phase 2)Study completedNCT00276679What this trial is testingTemozolomide in Treating Young Patients With High-Risk Relapsed or Refractory NeuroblastomaWho this might be right forNeuroblastoma Children's Cancer and Leukaemia Group
Early research (Phase 1)Study completedNCT00005946What this trial is testingChemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell TransplantationWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more University of Maryland, Baltimore
Testing effectiveness (Phase 2)UnknownNCT04615468What this trial is testingTQ-B3525 in Subjects With Relapsed/Refractory Peripheral T-cell Lymphoma（PTCL）Who this might be right forPeripheral T-cell Lymphoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 78
Large-scale testing (Phase 3)Ended earlyNCT03504410What this trial is testingEfficacy/Safety of CPI-613 in Combination With HD Cyt. and Mito. vs HD Cyt. and Mito. in Older Patients With R/R AMLWho this might be right forRelapsed/Refractory Acute Myeloid Leukemia Cornerstone Pharmaceuticals 200
Not applicableStudy completedNCT00296023What this trial is testingDonor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more University of California, San Francisco 25
Testing effectiveness (Phase 2)Looking for participantsNCT05327023What this trial is testingDonor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic MalignanciesWho this might be right forHematologic Neoplasms National Cancer Institute (NCI) 430
Early research (Phase 1)Looking for participantsNCT06873659What this trial is testingSON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid TumorsWho this might be right forSolid TumorGastric CancerLiver Cancer Qurgen Inc. 96
Very early researchLooking for participantsNCT04657861What this trial is testingAPRIL CAR-T Cell Therapy for Patients With BCMA/TACI Positive Relapsed and/or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma in RelapseMultiple Myeloma, Refractory Zhejiang University 36